-
公开(公告)号:US20140128576A1
公开(公告)日:2014-05-08
申请号:US14068670
申请日:2013-10-31
发明人: Jacqueline Benson , Mark Cunningham , Cynthia Duchala , Jill M. Giles-Komar , Jinquan Luo , Michael A. Rycyzyn , Raymond Sweet
IPC分类号: C07K16/24
CPC分类号: A61K39/3955 , A61K39/00 , A61K45/06 , A61K2039/505 , A61K2039/55527 , A61K2039/55544 , C07K16/244 , C07K2317/30 , C07K2317/33 , C07K2317/34 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/92 , C07K2319/55 , G01N33/6869 , G01N2333/54 , Y02A50/386 , Y02A50/401 , Y02A50/41 , Y02A50/412 , Y02A50/55 , Y02A50/57 , Y02A50/58
摘要: An anti-IL-23 antibody, including isolated nucleic acids that encode at least one anti-IL-23 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.
摘要翻译: 抗IL-23抗体,包括编码至少一种抗IL-23抗体,载体,宿主细胞,转基因动物或植物的分离的核酸及其制备和使用的方法具有诊断和/或治疗组合物中的应用 ,方法和设备。
-
公开(公告)号:US20140093508A1
公开(公告)日:2014-04-03
申请号:US13973187
申请日:2013-08-22
发明人: Mark Cunningham , Yiqing Feng , Katharine Heeringa , Jinquan Luo , Robert Rauchenberger , Mark Rutz , Lani San Mateo , Robert Sarisky , Raymond Sweet , Fang Teng , Alexey Teplyakov , Sheng-Jiun Wu
IPC分类号: C07K16/28
CPC分类号: C07K16/2896 , A61K39/39533 , A61K39/3955 , A61K2039/505 , C07H21/04 , C07K14/705 , C07K16/18 , C07K16/28 , C07K16/2863 , C07K2317/21 , C07K2317/24 , C07K2317/33 , C07K2317/34 , C07K2317/51 , C07K2317/515 , C07K2317/52 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/92 , C07K2317/94 , C12N5/10 , C12N5/12 , C12N15/117 , C12N15/63 , C12N2310/17 , A61K39/00 , A61K2300/00
摘要: Toll Like Receptor 3 (TLR3) antibody antagonists, polynucleotides encoding TLR3 antibody antagonists or fragments thereof, and methods of making and using the foregoing are disclosed.
摘要翻译: 公开了Toll样受体3(TLR3)抗体拮抗剂,编码TLR3抗体拮抗剂或其片段的多核苷酸,以及制备和使用前述物质的方法。
-
公开(公告)号:US20240199733A1
公开(公告)日:2024-06-20
申请号:US18444595
申请日:2024-02-16
发明人: Jacqueline Benson , Jill Carton , Mark Cunningham , Yevgeniya Orlovsky , Robert Pauchenberger , Raymond Sweet
CPC分类号: C07K16/244 , A61K9/0019 , A61K9/08 , A61K39/3955 , A61K47/26 , A61K2039/505 , C07K2317/21 , C07K2317/34 , C07K2317/52 , C07K2317/55 , C07K2317/565 , C07K2317/73 , C07K2317/76 , C07K2317/92 , C07K2319/00 , C07K2319/30
摘要: A human anti-IL-23p19 antibody, including isolated nucleic acids that encode at least one anti-IL-23p19 antibody, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.
-
公开(公告)号:US11939375B2
公开(公告)日:2024-03-26
申请号:US17181778
申请日:2021-02-22
发明人: Jacqueline Benson , Jill Carton , Mark Cunningham , Yevgeniya Orlovsky , Robert Rauchenberger , Raymond Sweet
CPC分类号: C07K16/244 , A61K9/0019 , A61K9/08 , A61K39/3955 , A61K47/26 , A61K2039/505 , C07K2317/21 , C07K2317/34 , C07K2317/52 , C07K2317/55 , C07K2317/565 , C07K2317/73 , C07K2317/76 , C07K2317/92 , C07K2319/00 , C07K2319/30
摘要: A human anti-IL-23p19 antibody, including isolated nucleic acids that encode at least one anti-IL-23p19 antibody, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.
-
公开(公告)号:US20210188966A1
公开(公告)日:2021-06-24
申请号:US17181778
申请日:2021-02-22
发明人: Jacqueline Benson , Jill Carton , Mark Cunningham , Yevgeniya Orlovsky , Robert Rauchenberger , Raymond Sweet
IPC分类号: C07K16/24 , A61K9/00 , A61K9/08 , A61K39/395 , A61K47/26
摘要: A human anti-IL-23p19 antibody, including isolated nucleic acids that encode at least one anti-IL-23p19 antibody, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.
-
公开(公告)号:US10954297B2
公开(公告)日:2021-03-23
申请号:US16013141
申请日:2018-06-20
发明人: Jacqueline Benson , Jill Carton , Mark Cunningham , Yevgeniya Orlovsky , Robert Rauchenberger , Raymond Sweet
摘要: A human anti-IL-23p19 antibody, including isolated nucleic acids that encode at least one anti-IL-23p19 antibody, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.
-
公开(公告)号:US10576150B2
公开(公告)日:2020-03-03
申请号:US16358775
申请日:2019-03-20
发明人: Jacqueline Benson , Mark Cunningham , Cynthia Duchala , Jill Giles-Komar , Jinquan Luo , Michael Rycyzyn , Raymond Sweet
IPC分类号: A61K39/395 , G01N33/68 , C07K16/24 , A61K45/06 , A61K39/00
摘要: An anti-IL-23 antibody, including isolated nucleic acids that encode at least one anti-IL-23 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.
-
公开(公告)号:US20190201527A1
公开(公告)日:2019-07-04
申请号:US16358775
申请日:2019-03-20
发明人: Jacqueline Benson , Mark Cunningham , Cynthia Duchala , Jill Giles-Komar , Jinquan Luo , Michael Rycyzyn , Raymond Sweet
IPC分类号: A61K39/395 , C07K16/24 , A61K45/06 , G01N33/68
摘要: An anti-IL-23 antibody, including isolated nucleic acids that encode at least one anti-IL-23 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.
-
公开(公告)号:US20180291096A1
公开(公告)日:2018-10-11
申请号:US16013141
申请日:2018-06-20
发明人: Jacqueline Benson , Jill Carton , Mark Cunningham , Yevgeniya Orlovsky , Robert Rauchenberger , Raymond Sweet
摘要: A human anti-IL-23p19 antibody, including isolated nucleic acids that encode at least one anti-IL-23p19 antibody, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.
-
公开(公告)号:US10030070B2
公开(公告)日:2018-07-24
申请号:US15694107
申请日:2017-09-01
发明人: Jacqueline Benson , Jill Carton , Mark Cunningham , Yevgeniya I. Orlovsky , Robert Rauchenberger , Raymond Sweet
摘要: A human anti-IL-23p19 antibody, including isolated nucleic acids that encode at least one anti-IL-23p19 antibody, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.
-
-
-
-
-
-
-
-
-